Exploring the tumor-promoting function and prognostic value of ESPL1 in prostate adenocarcinoma
Our findings suggest that ESPL1 contributes to PRAD progression by regulating proliferation and apoptosis, potentially serving as both a prognostic biomarker and a candidate target for therapeutic development.
Authors
- Shuaijie Wang (ORCID: https://orcid.org/0009-0007-7228-1146)
- Xuan Meng (ORCID: https://orcid.org/0000-0003-2355-4068)
- Yuzhong Yang (ORCID: https://orcid.org/0000-0001-6663-1268)
- Yiping Sun
- Shaohua Chen (ORCID: https://orcid.org/0000-0002-8064-0504)
- Peng Pan (ORCID: https://orcid.org/0009-0003-8351-4671)
- Xuemei Zhang (ORCID: https://orcid.org/0000-0003-3970-7110)
Institutions
- Guilin Medical University (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1016/j.urolonc.2025.09.007
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00